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August 2012580 AbstractsAn 18-Year Experience Utilizing Distal Revascularization With Inter-
val Ligation (DRIL) as the Primary Treatment for Hand Ischemia
Following Dialysis Access Creation
Rahim Aimaq, MD, and Steven Katz, MD. Vascular Surgery, Huntington
Memorial Hospital, Pasadena, Calif
Objective: Arterial steal syndrome after angioaccess surgery can lead to
potentially devastating complications. Past treatments ensured loss of the
newly created access by performing ligation or attempted salvage by increas-
ing resistance within the fistula. None of these proved to be entirely
satisfactory. In 1994, we began to use distal revascularization with interval
ligation (DRIL) as our primary method of relieving hand ischemia after
dialysis access creation. We describe our experience with this procedure.
Methods: After Investigational Review Board approval, the records of
all patients undergoing the DRIL procedure for relief of hand ischemia after
dialysis access surgery were reviewed. Patient demographics, risk factors,
type of fistula, and indications for operation were recorded. The clinical
results of DRIL surgery, duration of fistula use for dialysis, and bypass graft
patency were noted. Kaplan-Meier survival curves were created, and differ-
ences between groups were tested by the log-rank method. Fistula survival
was defined as the duration of use before abandonment as the primary
method of achieving dialysis access, and bypass graft survival was determined
by clinical examination or duplex scan.
Results: Between May 1994 and August 2011, 81 DRIL procedures
were performed on 77 patients (32 men, 45 women) with a mean age of 64
years (range, 37-91 years). Diabetes was present in 77.6%. DRIL procedures
were performed for ischemic symptoms after 51 autogenous fistulas (37 bra-
chiocephalic and 14 brachiobasilic), and 30 were created after prosthetic bridge
fistulas. Thirty-eight DRILS were performed for patients with ischemic rest
pain, 20 after the development of digital ulcers, 16 to help resolve neurologic
symptoms, and seven to heal digital gangrene. After performance of the DRIL
procedure, complete resolution of symptoms was noted in 90% of patients
treated for digital ulceration, 81.6% of patients treated for ischemic rest pain,
56.3% of patients treated for neurologic deficits, and 42.9% of patients treated
for digital gangrene. Overall fistula survival after the DRIL procedure was
70.1%, 57.8%, and 44.5% at 12, 24, and 36 months, respectively. Autogenous
fistulas had a significantly longer survival after DRIL than prosthetic bridge
fistulas (P .009). The 5-year patency of the brachial-brachial bypass graft was
93.7%. No patients died30 days of operation.
Conclusions: The DRIL procedure is a very effective treatment of hand
ischemia after dialysis access creation and can be performed with a low mortality.
It is extremely successful in treating ischemic rest pain and digital ulceration, but
less so when used to treat patients with digital gangrene and neurologic deficits.
Autogenous fistula survival after the creation of the DRIL is excellent and
considerably longer than that of prosthetic bridge fistulas.
Placement of a Brachial-Hemiazygous Arteriovenous Graft for Hemo-
dialysis Using the Gore Hybrid Graft
Swee Lian Tan, MD, PhD, and Robert B. Osnis, MD. Department of
Vascular Surgery, Swedish Medical Center, Seattle, Wash
Objective: To develop additional options for hemodialysis access after
common sites for arteriovenous (AV) fistulae and grafts have been ex-
hausted, but before resorting to higher-risk sites, such as the vena cava and
right atrium, we report the use of a new hybrid stent graft to access and
secure an AV graft to a traditionally difficult-to-expose and fragile vein.
Methods: We identified a patient with end-stage renal disease with a
failing cross-pubic femoral artery-to-external iliac vein graft with a history of
multiple failed AV grafts and central venous occlusions. The patient was no
longer a candidate for peritoneal dialysis or renal transplant. A 9-mm Gore
Hybrid graft was introduced into the hemiazygous vein percutaneously
through a site at the base of the neck. After the stent portion of the graft was
deployed in the vein, the graft was placed in a subcutaneous tunnel from the
neck to the left brachial artery, where a conventional anastomosis was
performed. In another patient, the same technique was used to implant an
AV graft between the subclavian vein and the brachial artery.
Results: The graft was successfully placed without complication, and
dialysis pump speeds of 400 mL/min were achieved.
Conclusions: The Gore Hybrid graft has been primarily used to
simplify and speed placement of AV grafts using conventional vessels.
However, in patients where those vessels are no longer available, it can also
be used on vasculature that has been considered too difficult or risky to use
as a graft site using traditional surgical techniques.
Routine Genetic Testing Should be Standard of Care for Patients
Receiving Oral Anticoagulants
Karthik Kasirajan, MD,1 and Stephen Murray, MD2. 1NMTC, Walnut
Creek, Calif; and 2Providence Hospital, Spokane, Wash
Objective: A significant number of patients who receive anticoagulants
experience major or minor bleeding events or continue to experience
thrombotic complications. Black box warnings on the labels of the two most
commonly prescribed oral anticoagulants (clopidogrel and warfarin) inform
physicians that genetic differences can reduce or augment drug effectiveness.
f
they additionally include information on the available genetic tests:
YP2C19 status for clopidogrel andCYP2C9/VKORC1 status for warfarin.
his study assessed the incidence of gene variations that may influence
atient response to both drugs.
Methods: Molecular laboratory analysis was performed from four
uccal swabs done on each patient. CYP2C19 (n 6664) test subjects were
lassified as normal, normal intermediate, intermediate, poor, rapid, or
ltrarapid metabolizers. CYP2C9 (n 6073) test subjects were classified as
ormal, intermediate, or poor metabolizers. VKORC1 (n  6066) test
ubjects were classified as low, intermediate, or high sensitivity.
Results: Overall genetic variations that would affect clopidogrel effi-
acy were more common (n  4054 [60.8%]) compared with normal
etabolizers (n  2610 [39%]). Poor and ultrarapid metabolizers ac-
ounted for 3% and 4%, respectively. Genetic variations that would affect
arfarin metabolism in the CYP2CP assay were noted in 1700 patients
28%). VKORCI assay was nonintermediate (low and high sensitivity) in
424 patients (56.5%).
Conclusions: A significant percentage of the patients taking oral antico-
gulants, especially clopidogrel, have genetic variations that determine drug
fficacy. On the basis of our study, we would recommend that patients receiving
rugs with a narrow therapeutic margin should have a mandatory molecular
rofiling to best determine a safe, effective and individualized drug dosage.
able. Phenotype of genetic assay
ssay response No. (%)
YP2C19
Normal 2610 (39.2)
Poor/intermediate 1954 (29.3)
Rapid/ultrarapid 2100 (31.5)
YP2CP
Normal 4373 (72)
Intermediate 1552 (25.6)
Poor 148 (2.4)
KORC1
Low 2672 (44)
Intermediate 2642 (43.6)
High 752 (12.4)
mportance of Intravascular Ultrasound Imaging During Percutane-
us Treatment of May-Thurner Syndrome
rian G. DeRubertis, MD, Wesley Lew, MD, Sinan Jabori, Andy Barleban, MD,
uan Carlos Jimenez, MD, and Peter F. Lawrence, MD. Division of
ascular Surgery, University of California-Los Angeles School of Medicine,
os Angeles, Calif
Objective: May-Thurner (MT) compression of the left common iliac
LCIV) vein can present as unilateral leg swelling with or without associated
eep vein thrombosis (DVT). This report describes our diagnostic approach
with emphasis on the importance of intravascular ultrasound imaging),
anagement, and outcome in these patients.
Methods: This was a retrospective analysis of all patients evaluated for
T from 2006 to 2011.
Results: MT was diagnosed in 27 patients (63% female) who presented
ith unilateral left leg swelling, with (n  15, thrombotic) or without (n 
2, nonthrombotic) associated DVT. All patients underwent duplex imag-
ng and contrast angiography, and intravascular ultrasound (IVUS) imaging
as performed in 11 (83% of those with nonthrombotic MT). Mean age was
2.9 years. Prior DVT, pulmonary embolism, and hypercoagulable state
ere each present in 25% of nonthrombotic patients and in 80%, 33%, and
3% of thrombotic patients, respectively. Pain and swelling were present in
ll patients, and venous claudication was present in 63%. At presentation, all
onthrombotic patients were CEAP C3; thrombotic patients were C3
86.7%) or C6 (13.3%). Four of the nonthrombotic patients were treated
onservatively. Eight underwent LCIV stenting, leading to reduction or
melioration of symptoms in 87.5% and a decreased CEAP score in 75%. For
hrombotic patients, all but one underwent LCIV stenting (with or without
ysis), resulting in alleviation or amelioration of symptoms in 100% and
ecreased CEAP score in 85.7%. Angiographic findings in nonthrombotic
atients included LCIV stenosis, collateralization, and contrast stagnation in
1.7%, 83.3%, and 75% respectively. However, contrast angiography overesti-
ated LCIV minimum diameter by 61% (7.0 vs 4.2 mm) and cross-sectional
rea by twofold (104 vs 53 cm2) relative to IVUS imaging. Correction of LCIV
ompression in nonthrombotic patients was associated with a threefold increase
n mean cross-sectional area (53 to 166 cm2). One-year primary patency (mean
ollow-up, 9.7 months) was 100% for nonthrombotic patients and 78.6% for
hrombotic patients, with 100% secondary patency for both. Complications
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Volume 56, Number 2 Abstracts 581included two early reocclusions (treated with reintervention). There were no
pulmonary embolisms or death.
Conclusions: Excellent 1-year patency rates and a significant reduction
in symptoms and CEAP class can be attained with percutaneous intervention
for MT syndrome. IVUS imaging is essential for accurate diagnosis and stent
sizing in patients with nonthrombotic MT syndrome.
Comparative Effectiveness of Endovascular and Open Surgical Revas-
cularization in Diabetic Patients With “Critical Limb Ischemia” (Ruth-
erford 5 and 6) Due to Severe Tibial Artery Occlusive Disease
Luke X. Zhan, MD, PhD, Magdiel Trinidad-Hernandez, MD,
David G. Armstrong, MD, PhD, DPM, and
Joseph L. Mills, Sr, MD. Department of Surgery, University of Arizona,
Tucson, Ariz
Objective: The original 1982 definition of “critical limb ischemia”
(CLI) excluded patients with diabetes. Although endovascular therapy
(ENDO) has become the dominant revascularization method, its effective-
ness for tibial disease compared with bypass surgery (OPEN) in diabetic
individuals with CLI is unclear. Assessment of revascularization outcomes is
difficult in diabetic patients due to neuropathy, wounds, and infection. We
evaluated and compared outcomes in such patients using validated risk
stratification schemes (Prevent III and FinnVasc) and the Society for Vas-
cular Surgery (SVS) objective performance goals (OPGs).
Methods: We studied 94 consecutive tibial/pedal interventions in 70
limbs of 59 diabetic patients (64% men) with CLI who initially underwent
ENDO (n  37) or OPEN (n  33). Mean age was 69 years, and all had
tissue loss (Rutherford 5-6). We evaluated Prevent III and FinnVasc scores
in both groups. We compared wound healing time (WHT) and major SVS
OPGs, including 1-year amputation-free survival rate, major adverse limb
events, and major adverse cardiac events.
Results: Prevent III and FinnVasc preintervention risk scores were
similar in both groups. Limb salvage rates and WHT were also comparable,
but there was a trend toward faster WHT for OPEN. There were no
significant differences between groups regarding amputation-free survival
rate, major adverse limb events, and major adverse cardiac events.
Conclusions: This is the first study to assess outcomes of tibial revas-
cularization in diabetic patients with CLI using current risk stratification
schemes and SVS OPGs. ENDO and OPEN both met the target 1-year
amputation-free survival SVS OPG of 70%, suggesting that with proper
selection, each therapy is efficacious. Existing risk factor stratification scores
are suboptimal predictors of amputation and major adverse events in such a
heterogeneous group of patients. Important variables that influence therapy and
outcomes, such as patient factors (functional status, life expectancy), wound
factors (presence, depth, and location), infection (presence, severity, and ex-
tent), conduit availability, target availability, and outflow are lacking, suggesting
the need for a new classification system for CLI in this growing subgroup.
Table. Risk stratification and comparison of outcomes
with Society for Vascular Surgery Objective Performance
Goals
Variable ENDO (N  37) OPEN (N  33) P
Prevent III, mean  SD 5.39  1.97 5.24  1.87 .7457
FinnVasc, mean  SD 2.16  0.83 2.52  0.91 .088
1 year AFS, % 83.8 69.7 .25
WHT, days (95% CI) 227.4 (177.3-277.5) 174.6 (132.3-216.9) .18
MALE, % 43.2 45.5 1
MACE, % 2.7 3.0 1
CI, confidence interval; MACE, Major adverse cardiac events; MALE, major
adverse limb events; SD, standard deviation; WHT, wound healing time.
Axillary Branch Artery Aneurysms: A Rare Cause of Upper Extremity
Ischemia in High-Performance Athletes
Jason T. Lee, MD, Venita Chandra, MD, Timothy McAdams, MD, and
Cornelius Olcott IV, MD. Division of Vascular Surgery, Stanford Univer-
sity Medical Center, Palo Alto, Calif
Objective: Axillary artery branch aneurysms (AABA) occur due to
extreme repetitive upper extremity effort and can result in hand ischemia
from embolic occlusion. Because these are found in otherwise healthy
high-performance athletes, the diagnosis is often missed or delayed. We
describe two cases of AABA resulting in thromboembolism and hand
ischemia in two nationally competitive athletes.
Methods: Preoperative imaging and perioperative findings were re-
viewed in two patients.
Results: A 57-year old senior United States Tennis Association player
in the national finals presented with right upper extremity paraesthesias
associated with diminished pulses and weakness after a vigorous match. The
p
matient underwent upper extremity angiography and subsequent thrombol-
sis, demonstrating a posterior circumflex humeral AABA (Fig 1, a) that had
mbolized to his wrist (Fig 1, b). Treatment with suture ligation (Fig 1, c)
nd anticoagulation allowed him to recover without recurrent ischemia, and he
layed in the national finals. A 17-year-old starting quarterback for a division I
ootball program noted progressive thumb pain and ischemia over the last four
ames of his freshman season, necessitating wearing gloves and placing his hand
n warm water after games. Angiography and computed tomography angiogra-
hy confirmed a similar AABA (Fig 2, a), and angiography confirmed emboli-
ation to digital arteries of the thumb (Fig 2, b). He was treated with anticoag-
lation and similar ligation to prevent future embolic events (Fig 2, c). He has
eturned to starting quarterback for his sophomore season.
Conclusions: These cases highlight AABAs resulting from recurrent
pper extremity trauma and subsequent thrombosis and embolism to the
and and wrist. Treatment entails thrombolysis or anticoagulation, or both,
nd then ligation of the branch to prevent future embolic potential. A high
ndex of suspicion for axillary artery pathology should be present when high
erformance athletes with repetitive overhead motions present with upper
xtremity arterial insufficiency.
ndoscopic Vein Harvest for Infra-inguinal Arterial Bypass
arah Wartman, MD, Gabriel Herscu, MD, Karen Woo, MD,
ichael Morell, Vahagn Nikolian, Miguel Manzur, and
red Weaver, MD. Keck Medical Center, University of Southern Califor-
ia, Los Angeles, Calif
Objective: Endoscopic harvest (EH) of saphenous vein for lower
xtremity bypass decreases length of incisions and was initially thought to
ecrease wound complication rates without adversely affecting patency.
owever, recent studies have shown lower patency without a wound com-
lication benefit. We sought to further study the wound complication and
atency rates of EH compared with open harvest (OH) techniques in
nfrainguinal arterial bypass procedures.
Methods: Infrainguinal bypasses performed between 2000 and 2011
ere analyzed. Only procedures using a single segment of great saphenous
ein were included. Patients were grouped according to EH or OH. The two
roups were frequency-matched for body mass index and diabetes. Baseline
haracteristics were compared. Univariate and multivariate analysis was
erformed, as appropriate, to determine correlation of baseline data and
arvest method on patency.
Results: The study included 76 bypasses: 35 in the EH group and 41
n the OH group. Baseline characteristics between the OH and EH groups
ere not significantly different. Mean age was 72 years in the EH group and
7 years in the OH group. The difference in the numbers of men and women
etween the two groups was not significant. Mean follow-up was 747 days.
here was no significant difference between the EH and OH groups in
0-day wound complication rates (29% vs 27%; P  .86), 3 year primary
atency rates (47% vs 49%, P .82), or 3 year primary assisted patency rates
88% vs. 76%, P .2). There was a trend toward increased secondary patency
n the EH group (92% vs 73%, P  .053). High body mass index improved
rimary patency (hazard ratio [HR], 0.89; 95% confidence interval [CI],
.82-0.97). Patients requiring hemodialysis had increased risk for loss of
rimary assisted patency (HR, 12.05; 95% CI 3.19-45.57) and secondary
Fig.atency (HR, 5.27; 95% CI 1.60-17.34). This remained significant on
ultivariate analysis when accounting for type of vein harvest.
